Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital271 Beijing Tiantan Hospital219 Cancer Institute and Hospital, Chinese Academy of Medical Sciences205 AstraZeneca191 Peking University People's Hospital166
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Beijing

5576 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Phase 1/2
55
Hefei, Beijing, Guangzhou, Shenzhen, Wuhan, Changsha, Nanjing, Chengdu
2026-08
Not yet open
Remimazolam Versus Propofol for Early Recovery After Cytoreductive Surgery
NCT07785557Peritoneal Neoplasms, Postoperative Recovery
DrugsRemimazolam·Propofol
Beijing Tsinghua Chang Gung Hospital
Not applicable
320
Beijing
2026-08
Not yet open
Lepu Biopharma Co., Ltd.
Phase 1/2
316
Beijing
2026-08
Not yet open
Fuyang Jiedu Granules Plus Antiretroviral Therapy for HIV Immune Non-Responders With Spleen-Kidney Yang Deficiency
NCT07698548HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder
Beijing University of Chinese Medicine
Not applicable
240
Beijing
2026-08
Not yet open
Qing Yuan
Not applicable
300
Beijing
2026-08
Not yet open
Laekna Limited
Phase 1
150
Hefei, Beijing, Changchun, Shanghai, Hangzhou
2026-08
Not yet open
Vigonvita Life Sciences
Phase 2
500
Beijing
2026-07-31
Recruiting
Tianjin Medical University Cancer Institute and Hospital
Phase 2
120
Beijing, Zhengzhou, Shenyang, Taiyuan, Chengdu, Tianjin
2026-07-31
Not yet open
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1
15
Beijing
2026-07-31
Not yet open
Chongqing Jinsaixing Medical Technology Co., Ltd
Observational
570
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Changchun, Shanghai, Chengdu
2026-07-31
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007Atherosclerosis, Coronary Artery Disease
Beijing Inno Medicine Co., Ltd.
Phase 2
456
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Daqing, Harbin, Wuhan
2026-07-31
Not yet open
Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)
NCT07717580Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Primary Cutaneous Anaplastic Large Cell Lymphoma
DrugsBrentuximab Vedotin·Lisaftoclax
Peking University First Hospital
Phase 2
46
Beijing
2026-07-31
Not yet open
Peking University Cancer Hospital & Institute
Observational
84
Beijing
2026-07-31
Not yet open
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
NCT07708285NF2-related Schwannomatosis, NF2, Neurofibromatosis Type 2, Vestibular Schwannoma
DrugsLuvometinib·Serplulimab
Beijing Tiantan Hospital
Phase 1/2
30
Beijing, Changchun, Shanghai
2026-07-31
Not yet open
A Randomized Controlled Trial of Autostereoscopic 3D Vision Therapy for Amblyopia
NCT07709832Amblyopia, Visual Training, Visual Functions, Visual Health
Beijing Tongren Hospital
Not applicable
34
Beijing
2026-07-31
Not yet open
Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT07721012Patients With Irritable Bowel Syndrome With Diarrhea
Lei Yunshang Group
Phase 2
120
Beijing, Changsha, Daqing, Guangzhou, Hohhot, Lianyungang, Luoyang, Meihekou
2026-07-31
Recruiting
Beijing Shijitan Hospital, Capital Medical University
Not applicable
227
Beijing, Dalian, Heilongjiang, Shandong
2026-07-31
Recruiting
VelaVigo Bio Inc
Phase 1/2
230
Beijing, Shanghai, Hangzhou
2026-07-30
Recruiting
China-Japan Friendship Hospital
Not applicable
100
Beijing
2026-07-30
Active, closed
Liping Dou
Phase 2
32
Beijing
2026-07-30
Recruiting
Pfizer
Phase 3
336
Beijing, Shanghai
2026-07-30
Recruiting
LaNova Medicines Limited
Phase 2
108
Beijing
2026-07-29
Recruiting
Janssen Research & Development, LLC
Phase 2
68
Beijing, Cheng Du Shi, Chengdu, Guangzhou, Jinan, Shanghai, Tianjin
2026-07-28
Not yet open
Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults
NCT07638800Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
68
Beijing
2026-07-28
Recruiting
Sanofi
Phase 2
160
Beijing
2026-07-28
Recruiting
Nanjing Minova Pharmaceutical Co., Ltd.
Phase 1
52
Beijing
2026-07-28
Not yet open
Peking University Cancer Hospital & Institute
Phase 2
17
Beijing
2026-07-28
Not yet open
The COMBINE-AF Trial
NCT07633509Atrial Fibrillation (AF), Atrial Fibrillation Catheter Ablation
DrugEthanol
Yunlong Wang
Not applicable
430
Beijing, Nanjing
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 3
448
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Luoyang
2026-07-27
Recruiting
UCB Biopharma SRL
Phase 2
402
Beijing, Chengdu, Guangzhou, Hangzhou, Nanchang, Shenzhen, Shijiazhuang, Yangzhou SHI
2026-07-27
Recruiting
GlaxoSmithKline
Phase 3
800
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Wuhan
2026-07-27
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
20
Beijing, Changchun, Fuzhou, Jinan, Shanghai, Shijiazhuang, Taiyuan, Tianjin
2026-07-27
Not yet open
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
120
Beijing
2026-07-27
Recruiting
Bristol-Myers Squibb
Phase 2
254
Beijing, Chongqing, Guangzhou, Xinxiang, Shanghai
2026-07-27
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
82
Beijing
2026-07-23
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
97
Beijing
2026-07-23
Recruiting
Jacobio Pharmaceuticals Co., Ltd.
Phase 2
32
Beijing
2026-07-23
Recruiting
Janssen Research & Development, LLC
Phase 3
348
Beijing, Wuhu
2026-07-23
Recruiting
A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma
NCT07661537B-cell Non-Hodgkin Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
90
Beijing, Guangzhou
2026-07-23
Recruiting
Beijing Chao Yang Hospital
Not applicable
424
Beijing
2026-07-22
Recruiting
Sinomune Pharmaceutical Co., Ltd
Phase 1
64
Beijing
2026-07-21
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
48
Bengbu, Beijing, Chongqing, Foshan, Guangzhou, Shenzhen, Zhuhai, Shijiazhuang
2026-07-21
Recruiting
A Phase I Clinical Trial to Evaluate CMS-F021 Following Single and Multiple Doses in Healthy Participants
NCT07790770Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria
Dermavon Holdings Limited
Phase 1
72
Beijing
2026-07-21
Recruiting
Boehringer Ingelheim
Phase 3
35
Beijing, Changsha, Shanghai
2026-07-21
Recruiting
Newish Biotech (Wuxi) Co., Ltd.
Phase 1
10
Beijing
2026-07-20
Recruiting
Junwei Hao, MD
Observational
50
Beijing
2026-07-20
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Not yet open
Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
NCT07713745Neurofibromatosis Type 2, Vestibular Schwannoma, Non-vestibular Schwannoma, Meningioma
DrugsLuvometinib·Selumetinib·Serplulimab
Beijing Tiantan Hospital
Phase 2
200
Beijing, Changchun, Shanghai
2026-07-18
Recruiting
Groovy Medicine (Hangzhou) Ltd.
Phase 1
100
Beijing, Langfang, Hangzhou
2026-07-17
Recruiting
Zhejiang Vimgreen Pharmaceuticals, Ltd.
Phase 2/3
152
Beijing
2026-07-17
Recruiting
China National Center for Cardiovascular Diseases
Observational
436
Beijing
2026-07-17
Recruiting
AstraZeneca
Phase 3
915
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou
2026-07-16
Recruiting
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
156
Bozhou, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-07-16
Recruiting
Novartis Pharmaceuticals
Phase 3
570
Beijing
2026-07-16
Recruiting
Chinese PLA General Hospital
Phase 1
9
Beijing
2026-07-16
Recruiting
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 1
36
Beijing, Wuhan, Shenyang, Jinan
2026-07-16
Not yet open
Xuanwu Hospital, Beijing
Observational
5
Beijing
2026-07-15
Recruiting
Peking University People's Hospital
Phase 2
120
Beijing
2026-07-15
Active, closed
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Beijing
2026-07-15
Recruiting
Lanyue Biotech (Hangzhou) Co., Ltd.
Phase 1/2
11
Beijing, Shanghai, Hangzhou
2026-07-15
Not yet open
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
NCT07711678Obstructive Sleep Apnea (OSA), Syndrome, Obstructive Sleep Apnea, Respiration Disorders, Sleep Apnea Syndrome, Obstructive
Beijing Pins Medical Co., Ltd
Not applicable
10
Beijing
2026-07-15
Recruiting
Implantable Wireless Brain-Computer Interface Systems in Patients With Tetraplegia
NCT07784088Spinal Cord Injury Cervical, Tetraplegia/Tetraparesis, Spinal Cord Injuries (SCI)
BCIFlex Medical Technology Co., Ltd.
Not applicable
34
Beijing
2026-07-15
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
150
Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Guilin, Nanning
2026-07-15
Not yet open
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1/2
120
Beijing
2026-07-15
Not yet open
Development and Validation of a Colorectal Cancer Diagnostic Model
NCT07692555Colorectal Cancer, Advanced Neoplasia, Prediction Models, Risk Stratification
Peking University Cancer Hospital & Institute
Observational
20,000
Beijing, Fuzhou, Xiamen, Yinchuan
2026-07-15
Recruiting
Early Identification and Diagnosis of BAD-related Stroke
NCT07693816Branch Atheromatous Disease, Acute Ischemic Stroke, Cerebral Infarction
Peking Union Medical College Hospital
Observational
1,602
Beijing
2026-07-15
Not yet open
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
NCT07762547Moyamoya Disease, Moyamoya Syndrome, Aspirin, Remote Ischemic Conditioning
Beijing Tiantan Hospital
Not applicable
724
Beijing
2026-07-15
Recruiting
A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
NCT07708753Platinum-resistant Ovarian Cancer, Platinum-resistant Primary Peritoneal Cancer, Platinum-resistant Fallopian Tube Cancer
DrugsLiposomal doxorubicin, Paclitaxel·SYS6043·Topotecan
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 3
460
Beijing
2026-07-15
Recruiting
Toludesvenlafaxine for Non-specific Low Back Pain
NCT07709416Non-specific Low Back Pain
Beijing Tiantan Hospital
Not applicable
132
Beijing
2026-07-15
Not yet open
Peking University Third Hospital
Not applicable
84
Beijing
2026-07-15
Not yet open
Peking Union Medical College Hospital
Not applicable
300
Cangzhou, Beijing
2026-07-15
Not yet open
Peking University People's Hospital
Phase 2
32
Beijing
2026-07-15
Recruiting
China-Japan Friendship Hospital
Not applicable
120
Beijing
2026-07-14
Recruiting
To Evaluate the Safety and Efficacy of RP902 Tablets
NCT07579884Mild Cognitive Impairment (MCI)
Risen (Suzhou) Pharma Tech Co., Ltd.
Phase 2
360
Beijing
2026-07-14
Recruiting
Angitia Biopharmaceuticals Guangzhou Limited
Phase 2
48
Beijing, Shenzhen, Changsha, Suzhou, Shanghai
2026-07-14
Recruiting
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
240
Beijing, Jinan
2026-07-14
Recruiting
Hangzhou Endonom Medtech Co., Ltd.
Not applicable
216
Beijing
2026-07-13
Not yet open
Heart Health Research Center
Not applicable
260
Beijing, Luoyang
2026-07-13
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NCT07567625Acute Myocardial Infarction (AMI), ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Harbin Medical University
Not applicable
2,000
Harbin, Beijing, Cangzhou, Chengde, Chengdu, Dalian, Daqing, Hunan
2026-07-13
Not yet open
Peking University Third Hospital
Not applicable
628
Beijing
2026-07-13
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
236
Beijing, Shanghai
2026-07-13
Not yet open
Jiangsu Carephar Pharmaceutical Co., Ltd.
Phase 2
156
Beijing, Bengbu, Changsha, Chongqing, Fujian, Guangzhou, Hefei, Huizhou
2026-07-12
Not yet open
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
387
Beijing
2026-07-11
Not yet open
PulseMagic™ TrueForce™ PAF NMPA Study
NCT07720557Atrial Fibrillation (AF), Paroxysmal AF, Drug Refractory Paroxysmal Atrial Fibrillation, Atrial Arrhythmia
Shanghai MicroPort EP MedTech Co., Ltd.
Not applicable
150
Beijing
2026-07-10
Recruiting
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 1
40
Beijing
2026-07-10
Recruiting
Peking University Third Hospital
Not applicable
210
Beijing
2026-07-10
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Beijing
2026-07-10
Recruiting
Fujian Akeylink Biotechnology Co., Ltd.
Phase 2
80
Beijing
2026-07-10
Recruiting
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
NCT07684508Hypofractionated Radiotherapy, Intensity-modulated Radiotherapy, Cervical Cancers
Manni Huang
Not applicable
154
Beijing, Langfang
2026-07-10
Recruiting
Beijing HuiLongGuan Hospital
Not applicable
55
Beijing
2026-07-10
Active, closed
Beijing Tsinghua Chang Gung Hospital
Not applicable
76
Beijing
2026-07-10
Recruiting
Boehringer Ingelheim
Phase 3
390
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2026-07-10
Recruiting
18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
NCT07875959Renal Cell Carcinoma (RCC), Renal Pelvic Urothelial Carcinoma
Peking University First Hospital
Not applicable
80
Beijing
2026-07-09
Recruiting
Timing of ctDNA Testing in Advanced Breast Cancer
NCT07681323Advanced Breast Cancer
Geneplus-Beijing Co. Ltd.
Observational
400
Beijing
2026-07-08
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
398
Hefei, Beijing
2026-07-07
Not yet open
Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)
NCT07535489Moderately to Severely Active Ulcerative Colitis (UC)
Nanjing Immunophage Biotech Co., Ltd
Phase 2
144
Beijing
2026-07-07
Recruiting
Lepu Biopharma Co., Ltd.
Phase 2
80
Beijing, Fuzhou, Guangzhou, Shantou, Nanning, Shijiazhuang, Wuhan, Changsha
2026-07-06
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
446
Beijing
2026-07-06
Recruiting
Peking University People's Hospital
Phase 4
500
Beijing
2026-07-06
Recruiting
Chengdu Suncadia Medicine Co., Ltd.
Phase 2
380
Beijing
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Chenzhou, Chifeng
2026-07-06
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
12
Beijing
2026-07-06
Recruiting
Tingting Yuan
Phase 2
200
Beijing
2026-07-06
Recruiting
Peking University Third Hospital
Not applicable
360
Beijing
2026-07-06
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 3
84
Anyang, Beijing, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Hangzhou
2026-07-05
Recruiting
Mindfulness Intervention for Emotional Distress: An EEG Study
NCT07692269Emotional Distress, Anxiety, Depression, Stress (Psychology)
Peking University
Not applicable
160
Beijing
2026-07-04
Recruiting
Hoffmann-La Roche
Phase 3
300
Zhengzhou, Xianyang, Ningbo, Beijing, Changchun, Hefei, Herbin, Huai'an
2026-07-03
By invitation
Jiangsu Chuangyuan Life Science and Technology Co., Ltd.
Phase 1
74
Beijing, Zhengzhou, Nanjing
2026-07-03
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
46
Beijing
2026-07-03
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
551
Beijing, Jinan
2026-07-03
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
DrugPF-08634404
Pfizer
Phase 2
40
Beijing, Fuzhou, Zhengzhou, Wuhan, Nanchang, Shanghai, Hangzhou
2026-07-02
By invitation
Novo Nordisk A/S
Observational
216
Beijing, Chongqing, Lanzhou, Jiangmen, Langfang, Harbin, Shiyan, Huai'an
2026-07-02
Active, closed
Hoffmann-La Roche
Phase 1
36
Beijing
2026-07-02
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1
144
Beijing
2026-07-01
Not yet open
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
Early Phase 1
6
Yancheng, Beijing
2026-07-01
Recruiting
Chinese PLA General Hospital
Early Phase 1
30
Beijing
2026-07-01
Not yet open
Zishen Yutai Pill for Patients With Recurrent Implantation Failure
NCT07641088Recurrent Implantation Failure
Peking University Third Hospital
Not applicable
878
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Changsha, Nanjing, Xi'an
2026-07-01
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
140
Beijing
2026-07-01
Active, closed
Peking Union Medical College
Phase 2
50
Beijing
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
274
Beijing
2026-07-01
Recruiting
Peking University People's Hospital
Observational
140
Beijing
2026-07-01
Not yet open
AlphaMol Science Ltd. (Shanghai)
Phase 1
48
Beijing
2026-07-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
102
Beijing
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Distal Femoral Fractures
NCT07738406Supracondylar Femoral Fractures, Femoral Fractures
Beijing Jishuitan Hospital
Not applicable
80
Beijing
2026-07-01
Recruiting
Beijing Jishuitan Hospital
Not applicable
60
Beijing
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
91
Beijing
2026-07-01
Recruiting
Xuanwu Hospital, Beijing
Early Phase 1
5
Beijing
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
1,200
Beijing
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Intertrochanteric Femoral Fractures
NCT07738458Intertrochanteric Fractures, Intertrochanteric Fractures of the Hip, Intertrochanteric Fractures of the Femur
Beijing Jishuitan Hospital
Not applicable
60
Beijing
2026-07-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing, Shenzhen, Taiyuan
2026-07-01
Recruiting
Beijing Anzhen Hospital
Not applicable
136
Beijing
2026-07-01
Recruiting
Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft Fractures
NCT07738380Femoral Shaft Fractures, Femur Fractures, Femur Fracture
Beijing Jishuitan Hospital
Not applicable
80
Beijing
2026-07-01
Recruiting
Peking Union Medical College Hospital
Phase 2
40
Beijing
2026-07-01
Not yet open
Chinese PLA General Hospital
Not applicable
150
Beijing
2026-07-01
Recruiting
Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
NCT07689851Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma
DrugRetlirafusp alfa
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
60
Shenzhen, Taiyuan, Beijing
2026-07-01
Not yet open
Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia
NCT07569874Benign Prostatic Hyperplasia, Bladder Outlet Obstruction, Lower Urinary Tract Symptoms (LUTS)
Chinese PLA General Hospital
Not applicable
932
Beijing
2026-07
Not yet open
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
NCT07687667Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female
DrugMetformin
Peking University Third Hospital
Not applicable
406
Beijing
2026-07
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
127
Beijing, Lanzhou, Guangzhou, Anyang, Luoyang, Zhengzhou, Nanjing, Xuzhou
2026-07
Not yet open
Effects of Functional Oils on Obesity With Mild Cognitive Impairment
NCT07690384Obesity, Mild Cognitive Impairment
Capital Medical University
Not applicable
100
Beijing
2026-07
Recruiting
Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
NCT07719140Childhood-onset Systemic Lupus Erythematosus, Lupus Nephritis (LN)
DrugPrednisone
Peking Union Medical College Hospital
Phase 4
198
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Changchun, Shanghai
2026-07
By invitation
Compassionate Administration of ZVS101e for Extended Treatment
NCT07307469Bietti Crystalline Corneoretinal Dystrophy
DrugZVS101e
Chigenovo Co., Ltd
Not applicable
32
Beijing, Guangzhou, Zhengzhou, Chengdu, Tianjin
2026-07
Not yet open
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
404
Beijing, Kunming
2026-07
Not yet open
Peking University
Not applicable
480
Wuhu, Zhengzhou, Shenyang, Zibo, Shanghai, Hangzhou, Jinhua, Beijing
2026-07
Not yet open
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
NCT07714070Endometrial Neoplasms, Endometrial Cancer, Atypical Endometrial Hyperplasia, Progestin Resistance
DrugsOrlistat·Progestin
Peking University People's Hospital
Phase 2
48
Beijing
2026-07
Not yet open
Beijing Geekgene Technology Co., LTD
Early Phase 1
10
Beijing
2026-07
Recruiting
Climb Bio, Inc.
Phase 1/2
30
Mianyang, Baoji, Beijing, Bengbu, Changsha, Hefei, Nanchang, Suzhou
2026-06-30
Recruiting
Lefamulin Post-Market Surveillance Study
NCT07697885Community-Acquired Pneumonia (CAP)
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Observational
1,000
Beijing
2026-06-30
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
29
Beijing
2026-06-30
By invitation
Immunity in Critical Sepsis
NCT07770347Sepsis
Beijing Chao Yang Hospital
Not applicable
2,400
Beijing
2026-06-30
Recruiting
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH
NCT07581951MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH (Non-Alcoholic Steatohepatitis)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
886
Beijing
2026-06-30
Not yet open
Beijing GoBroad Hospital
Phase 2
40
Beijing
2026-06-30
Not yet open
GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma
NCT07670260Relapsed or Refractory Large B-cell Lymphoma
Chinese PLA General Hospital
Early Phase 1
9
Beijing
2026-06-30
By invitation
Beijing Chao Yang Hospital
Observational
2,400
Beijing
2026-06-30
Recruiting
Peking University Third Hospital
Observational
114
Beijing, Cangzhou, Chengdu
2026-06-30
Recruiting
Beijing Municipal Administration of Hospitals
Observational
40
Beijing
2026-06-30
Not yet open
Jing Liu
Not applicable
260
Beijing
2026-06-30
Not yet open
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
80
Beijing
2026-06-30
Not yet open
BOE Technology Group Co., Ltd.
Phase 1
35
Beijing
2026-06-30
Recruiting
Cold-Region Exposure and Cardiac Remodeling After PCI
NCT07773870Coronary Artery Disease, Percutaneous Coronary Intervention (PCI), Left Ventricular Remodeling, Cold Exposure
Chinese PLA General Hospital
Observational
400
Beijing
2026-06-30
Not yet open
Beijing Tongren Hospital
Phase 4
159
Beijing, Guangzhou, Shanghai, Xi'an, Zhongshan
2026-06-30
Recruiting
Pfizer
Phase 2
120
Beijing, Guangzhou, Jinan, Shanghai
2026-06-30
Recruiting
Bambusa Therapeutics
Phase 1/2
48
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jinzhou, Wuxi, Taiyuan, Xi’an
2026-06-29
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
538
Beijing
2026-06-29
Recruiting
BrightGene Bio-Medical Technology Co., Ltd.
Phase 2
200
Beijing
2026-06-29
Recruiting
Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD
NCT07667894Gastroesophageal Reflux Disease, Emotional Distress
Xinghua Liu
Not applicable
500
Beijing, Baiyin, Shenzhen, Guiyang, Xingtai, Xinle, Chifeng, Hohhot
2026-06-29
By invitation
Capital Medical University
Observational
868
Beijing
2026-06-28
Not yet open
Sinovac Life Sciences Co., Ltd.
Phase 3
600
Fuyang, Hefei, Beijing, Guangzhou, Shenzhen, Liuzhou, Zunyi, Shijiazhuang
2026-06-28
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 3
554
Beijing
2026-06-26
Recruiting
Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
NCT07724756Pediatric Malignant Solid Tumor, Febrile Neutropenia (FN), Neutropenia
Qilu Pharmaceutical Co., Ltd.
Phase 2
18
Beijing
2026-06-26
Recruiting
Jecho Biopharmaceuticals Co., Ltd.
Phase 1
14
Beijing
2026-06-25
Recruiting
GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders
NCT07660939Plasma Cell Disorders, Multiple Myeloma (MM)
Peking University First Hospital
Phase 1
50
Beijing
2026-06-25
Recruiting
Efgartigimod in Anti-NMDA Receptor Encephalitis.
NCT07822776Encephalitis Autoimmune
Beijing Tongren Hospital
Phase 2
20
Beijing
2026-06-25
Recruiting
Clinical Study of Coronary Extension Catheter
NCT07742345Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI)
BrosMed Medical Co., Ltd
Not applicable
69
Beijing
2026-06-25
Not yet open
Beijing Tiantan Hospital
Phase 4
12
Beijing
2026-06-24
Recruiting
Study of AHB-171 in Chronic Hepatitis B Participants
NCT07630727Hepatitis B, Chronic (CHB)
DrugAHB-171
Ausper Biopharma Co., Ltd.
Phase 2
138
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Zhengzhou, Changzhou, Jilin City
2026-06-24
Recruiting
AstraZeneca
Phase 2
84
Anyang, Beijing, Changsha, Chengdu, Chizhou, Haikou, Hefei, Hohhot
2026-06-24
Recruiting
Peking University Cancer Hospital & Institute
Phase 1/2
30
Beijing
2026-06-24
Recruiting
Shanghai Minwei Biotechnology Co., Ltd
Phase 2
240
Beijing
2026-06-23
Recruiting
AstraZeneca
Observational
2,000
Beijing, Chengdu, Fuzhou, Guangzhou, Nanchang, Shanghai, Shenyang, Shijiazhuang
2026-06-22
Recruiting
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
NCT07552610Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy, Neutrophil Extracellular Trap Formation
DrugSivelestat sodium
Xuanwu Hospital, Beijing
Not applicable
868
Weifang, Beijing
2026-06-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
960
Beijing, Shanghai
2026-06-22
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
198
Bengbu, Bozhou, Beijing, Chongqing, Lanzhou, Guangzhou, Jiangmen, Shenzhen
2026-06-22
Recruiting
Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
NCT07648823Recurrent Glioblastoma (WHO-Grade IV Glioma), Recurrent Glioblastoma, Glioblastoma (GBM), Recurrent Glioblastoma IDH Wildtype
Beijing Tiantan Hospital
Early Phase 1
5
Beijing
2026-06-20
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
200
Beijing
2026-06-20
Recruiting
Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison
NCT07808866Adverse Drug Reactions, Clinical Decision Support
Peking University Third Hospital
Observational
20,000
Beijing
2026-06-19
Recruiting
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase 3
840
Beijing
2026-06-19
By invitation
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xi’an
2026-06-18
Recruiting
CW-301 FIH Study of CAN016
NCT07664150Patients With Advanced Solid Tumors
Canwell Biotech Limited
Phase 1/2
90
Beijing
2026-06-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Hefei, Beijing, Xiamen, Guangzhou, Guilin, Nanning, Shijiazhuang, Wuhan
2026-06-18
Not yet open
Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)
NCT07668960High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Shanghai Mianyi Biopharmaceutical Co., Ltd.
Phase 1/2
60
Beijing, Chongqing, Zhangzhou, Jinan
2026-06-17
Recruiting
Vantive Health LLC
Observational
750
Beijing, Chongqing, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha
2026-06-17
Recruiting
CSL Behring
Phase 1
24
Beijing
2026-06-17
Recruiting
Risk Factor Assessment for Acute Pulmonary Hypertension Crisis
NCT07653958Pulmonary Hypertension, Pulmonary Hypertension Crisis
Peking Union Medical College Hospital
Observational
5,000
Guangzhou, Kunming, Beijing, Shanghai
2026-06-17
Recruiting
Full-Course ECMO Strategy for Moderate-to-Severe ARDS
NCT07726953Acute Respiratory Distress Syndrome
Southeast University, China
Not applicable
500
Beijing, Changchun, Chengdu, Chenzhou, Dalian, Fuzhou, Guangzhou, Hangzhou
2026-06-16
Active, closed
Chinese SLE Treatment And Research Group
Phase 4
15
Beijing
2026-06-16
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
92
Beijing
2026-06-16
Recruiting
Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
NCT07726940Acute Respiratory Distress Syndrome (ARDS)
Southeast University, China
Observational
1,776
Beijing, Fuzhou, Nanjing, Jinan, Chengdu, Hangzhou, Changchun, Chenzhou
2026-06-16
Not yet open
Danatlas Pharmaceuticals Co., Ltd
Phase 2
30
Guangzhou, Beijing
2026-06-15
Not yet open
Stellate Ganglion Block and Prognosis of Neurological Function After Subarachnoid Hemorrhage
NCT07652749Aneurysmal Subarachnoid Hemorrhage, Stellate Ganglion Block, Neurological Prognosis
Beijing Tiantan Hospital
Not applicable
560
Beijing
2026-06-15
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
649
Beijing
2026-06-15
Recruiting
yilong Wang
Early Phase 1
60
Beijing
2026-06-15
Recruiting
Merz North America, Inc.
Not applicable
218
Beijing, Guangzhou, Nanjing, Xi'an, Shanghai
2026-06-15
Recruiting
Beijing 302 Hospital
Phase 2
21
Beijing, Guangzhou, Shenzhen
2026-06-15
Recruiting
Peking Union Medical College Hospital
Observational
100
Beijing
2026-06-15
Not yet open
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
NCT07656740Gastrointestinal Cancer, Colorectal (Colon or Rectal) Cancer, Stomach (Gastric) Cancer
Peking University Cancer Hospital & Institute
Observational
50
Beijing
2026-06-15
Recruiting
Peking University People's Hospital
Not applicable
180
Beijing
2026-06-15
Recruiting
Peking University Third Hospital
Not applicable
80
Beijing
2026-06-15
Not yet open
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
NCT07699770Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
DrugCrisugabalin
Tang-Du Hospital
Phase 4
110
Beijing, Chongqing, Harbin, Hohhot, Changchun, Shenyang, Xi'an, Ürümqi
2026-06-15
Not yet open
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
210
Beijing
2026-06-15
Recruiting
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
NCT07606937Relapsed/Refractory Large B-cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Early Phase 1
12
Beijing, Guangzhou, Suzhou, Shanghai, Chengdu, Tianjin
2026-06-12
Active, closed
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
NCT07791602Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Cancer, HNSCC
DrugCamrelizumab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
180
Beijing, Harbin, Shenyang, Taiyuan, Tianjin
2026-06-12
Recruiting
68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma
NCT07590336Hepatocellular Carcinoma (HCC)
Peking Union Medical College Hospital
Phase 1/2
100
Beijing
2026-06-11
Recruiting
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase 1/2
24
Guangzhou, Shenyang, Beijing, Hangzhou, Shanghai, Taiyuan, Weifang, Wenzhou
2026-06-11
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Lanzhou, Nanchang, Nanjing
2026-06-11
Active, closed
AstraZeneca
Phase 2
326
Beijing, Changsha, Chongqing, Guangzhou, Hangzhou
2026-06-11
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 2
36
Beijing, Henan, Shanghai, Sichuan, Xiamen, Zhejiang
2026-06-10
Recruiting
Kexing Biopharm Co., Ltd.
Phase 1
18
Beijing
2026-06-10
Not yet open
Beijing Tiantan Hospital
Phase 1
20
Beijing
2026-06-10
Recruiting
yilong Wang
Early Phase 1
20
Beijing
2026-06-10
Recruiting
AstraZeneca
Not applicable
500
Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Guangzhou, Kunming, Quanzhou
2026-06-10
Not yet open
Beijing University of Chinese Medicine
Observational
453
Beijing
2026-06-10
Recruiting
Xuanwu Hospital, Beijing
Observational
1,000
Beijing
2026-06-10
Recruiting
CASI pharmaceuticals, Inc.
Phase 1/2
58
Beijing, Guangzhou, Wuhan, Xi'an
2026-06-09
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3
90
Beijing
2026-06-09
Recruiting
Sinocelltech Ltd.
Phase 3
93
Beijing
2026-06-09
Not yet open
Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit
NCT07670065Acute Ischemic Stroke, Large Vessel Occlusion
Beijing Tiantan Hospital
Phase 3
232
Beijing
2026-06-08
Recruiting
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
NCT07657793Systemic Lupus Erythematosus, Immune Thrombocytopenia
DrugSirolimus
Chinese SLE Treatment And Research Group
Phase 2/3
164
Beijing
2026-06-07
Not yet open
Akeso
Phase 1/2
286
Beijing, Harbin, Chengdu
2026-06-06
Recruiting
Chinese PLA General Hospital
Phase 1/2
24
Beijing
2026-06-05
Recruiting
Beijing Tiantan Hospital
Phase 3
934
Liaocheng, Beijing
2026-06-05
Recruiting
Ausper Biopharma Co., Ltd.
Phase 2
320
Beijing, Chongqing, Xiamen, Guangzhou, Jiangmen, Meizhou, Qingyuan, Shenzhen
2026-06-05
Recruiting
hUC-MSC-Exosomes for T2DM - Safety & Efficacy
NCT07693036Type 2 Diabetes Mellitus (T2DM)
Peking University First Hospital
Phase 1/2
66
Beijing
2026-06-05
Not yet open
Prime Gene Therapeutics Co., Ltd.
Phase 1
30
Beijing
2026-06-04
Recruiting
Takeda
Phase 2
92
Beijing, Guangzhou, Zhengzhou
2026-06-04
Recruiting
Sinocelltech Ltd.
Phase 3
101
Beijing
2026-06-04
Recruiting
Tooth and Bone-borne Cutting/Repositioning Guide and Patient-specific Implant(PSI)
NCT07634276CAD/CAM, Patient Specific Implant, Orthognathic Surgery, Surgery-first
Peking Union Medical College
Not applicable
50
Beijing
2026-06-03
Recruiting
Novo Nordisk A/S
Observational
470
Beijing
2026-06-03
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Chengdu, Beijing, Jinan, Shanghai, Suzhou, Wuhan
2026-06-03
Recruiting
Chengdu Kangnuoxing Biopharma,Inc.
Observational
1,000
Beijing
2026-06-02
Recruiting
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
6
Hefei, Beijing
2026-06-02
Not yet open
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642Uterine Cervical Neoplasms, Triple Negative Breast Neoplasms, Prostatic Neoplasms, Squamous Cell Carcinoma of Head and Neck
DrugGV20-0251
GV20 Therapeutics
Phase 2
227
Beijing, Harbin
2026-06-02
Recruiting
Xuanwu Hospital, Beijing
Not applicable
274
Beijing
2026-06-02
Recruiting
AstraZeneca
Not applicable
1,000
Anyang, Baoding, Beijing, Cangzhou, Changzhi, Chengdu, Fuzhou, Guangzhou
2026-06-02
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
1,472
Beijing
2026-06-02
Recruiting
Salt Sensitivity Evaluation Via N-of-1 Trials (SENSE-Salt)
NCT07614724Salt-Sensitivity of Blood Pressure, Hypertension
Peking University
Not applicable
72
Beijing
2026-06-02
Recruiting
Novartis Pharmaceuticals
Phase 4
36
Guangzhou, Shijiazhuang, Chengdu, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2026-06-01
Not yet open
A Multicenter Registry-Based Study Across the Spectrum of Degenerative Cervical Myelopathy
NCT07641699Degenerative Cervical Myelopathy, Non-myelopathic Degenerative Cervical Cord Compression, Asymptomatic Degenerative Cervical Cord Compression, Cervical Spinal Cord Compression
Wangjing Hospital, China Academy of Chinese Medical Sciences
Observational
200
Beijing
2026-06-01
Not yet open
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 1/2
15
Beijing, Shanghai
2026-06-01
Not yet open
Peking University Cancer Hospital & Institute
Not applicable
20
Beijing
2026-06-01
Not yet open
Chinese PLA General Hospital
Early Phase 1
60
Beijing
2026-06-01
Recruiting
[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
NCT07655869Recurrent High-Grade Gliomas, Recurrent Glioblastoma IDH Wildtype
Beijing Tiantan Hospital
Early Phase 1
24
Beijing
2026-06-01
Recruiting
Beijing Tiantan Hospital
Not applicable
150
Beijing
2026-06-01
Recruiting
Chinese PLA General Hospital
Phase 1
18
Beijing
2026-06-01
Recruiting
Chinese PLA General Hospital
Phase 1/2
24
Beijing
2026-06-01
Not yet open
Stratified Blood Pressure Management After Endovascular Treatment for Acute Ischemic Stroke
NCT07527013Endovascular Therapy, Acute Ischaemic Stroke, Collateral Circulation, Blood Pressure Management
Beijing Tiantan Hospital
Phase 3
544
Beijing
2026-06-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
50
Beijing
2026-06-01
Not yet open
Peking University People's Hospital
Observational
4,750
Beijing
2026-06-01
Not yet open
Peking University People's Hospital
Not applicable
50
Beijing
2026-06-01
Not yet open
Beijing Tongren Hospital
Not applicable
48
Beijing
2026-06-01
Not yet open
Efficacy and Safety of Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Intracranial Atherosclerotic Large Vessel Occlusion (ANGEL-REBOOT 2)
NCT07618052Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion, Acute Ischemic Stroke, Bailout Angioplasty or Stenting
Feng Gao
Not applicable
420
Beijing
2026-06-01
Recruiting
Liping Dou
Phase 2
120
Beijing
2026-06-01
Recruiting
Hangzhou Endonom Medtech Co., Ltd.
Not applicable
256
Beijing
2026-06-01
Not yet open
Feng Gao
Not applicable
240
Beijing
2026-06-01
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
390
Beijing
2026-06-01
Not yet open
Peking University People's Hospital
Observational
55
Beijing
2026-06-01
Recruiting
Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure
NCT07656168ESRD (End-Stage Renal Disease), Maintenance Hemodialysis
China-Japan Friendship Hospital
Not applicable
100
Beijing
2026-06-01
Recruiting
Jie Liang
Not applicable
600
Beijing, Shenyang, Xining, Xi'an, Shanghai, Changzhi, Linfen, Yuncheng
2026-06-01
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
76
Beijing, Guangzhou, Qingdao, Shanghai
2026-06-01
Recruiting
Beijing Anzhen Hospital
Not applicable
400
Beijing
2026-06-01
Recruiting
The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery
NCT07591207Loxoprofen Sodium Patch, Local Incision, Laparoscopic Cholecystectomy, Appendectomy, Laparoscopic
Beijing Tiantan Hospital
Not applicable
134
Beijing
2026-06-01
Not yet open
AI-Assisted Blood Pressure Control During Anesthesia
NCT07123675Intraoperative Hypotension, Hemodynamic Instability
Beijing Tsinghua Chang Gung Hospital
Not applicable
40
Beijing
2026-06-01
Not yet open
Chinese PLA General Hospital
Early Phase 1
250
Guangdong, Beijing
2026-06-01
Not yet open
CHIP-CC Registry: A Prospective Multicenter Registry of Complex High-Risk PCI in China
NCT07557238Coronary Artery Disease, High Risk PCI, Percutaneous Coronary Intervention (PCI)
Guofeng Gao
Observational
1,000
Beijing
2026-06-01
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
NCT06712654Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis
R1 Therapeutics
Phase 2
168
Beijing, Zhengzhou, Nanjing, Shanghai, Chengdu
2026-06-01
Recruiting
Peking Union Medical College Hospital
Observational
500
Beijing
2026-06-01
Recruiting
Shanghai Zhongshan Hospital
Observational
333
Beijing, Guangzhou, Shenzhen, Naning, Harbin, Zhengzhou, Wuhan, Nanjing
2026-06
Recruiting
A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
NCT07586735Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
Peking University People's Hospital
Observational
64
Beijing
2026-06
Not yet open
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
260
Bengbu, Hefei, Beijing, Chongqing, Lanzhou, Guangzhou, Zhanjiang, Nanning
2026-06
Not yet open
Beijing Geekgene Technology Co., LTD
Early Phase 1
10
Beijing
2026-06
Not yet open
Chengdu Kangnuoxing Biopharma,Inc.
Phase 2
15
Beijing
2026-06
Not yet open
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
NCT07593911Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN), Multiple Sclerosis, Myasthenia Gravis (MG)
DrugMTM-H-001
Beijing GoBroad Hospital
Not applicable
75
Beijing
2026-06
Recruiting
HBO After Thrombectomy for AIS With LVO
NCT07626450Acute Ischemic Stroke From Large Vessel Occlusion
Beijing Tiantan Hospital
Not applicable
420
Beijing
2026-06
Not yet open
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1
36
Beijing
2026-06
Not yet open
Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma
NCT07618793Lung Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung (NSCLC)
zhang yi
Phase 2
60
Beijing
2026-06
Not yet open
Targeted Temperature Management on Delayed Neurocognitive Recovery in Older Patients After Major Cancer Surgery
NCT07655687Elderly Patients, Cancer Surgery, Hypothermia, Accidental, Targeted Temperature Management
Peking University First Hospital
Not applicable
1,512
Beijing, Shenzhen
2026-06
Not yet open
Peking University First Hospital
Phase 4
60
Beijing
2026-06
Not yet open
CM336 for Active Sjogren's Syndrome Study
NCT07642843Primary Sjögren's Syndrome (pSS)
DrugCM336
Keymed Biosciences Co.Ltd
Phase 1
30
Beijing
2026-06
Not yet open
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
NCT07665827Nervous System Diseases, Cerebrovascular Disorders, Cardiovascular Diseases, Vascular Diseases
Xuanwu Hospital, Beijing
Not applicable
706
Beijing
2026-06
Not yet open
Treatment of Recurrent/Metastatic Head and Neck Cancer
NCT07601204Recurrent/Metastatic Head and Neck Cancer
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1/2
128
Beijing, Guangzhou, Nanning, Wuhan, Changsha, Shenyang, Taiyuan, Chengdu
2026-06
Not yet open
Intranasal Esketamine-dexmedetomidine Combination and Postpartum Depression
NCT07639099Parturients, Depressive Symptoms, Esketamine, Dexmedetomidine
Peking University First Hospital
Phase 4
164
Beijing
2026-06
Not yet open
Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease
NCT07658807Peripheral Arterial Disease, Diabetic Angiopathies, Arterial Occlusive Diseases
DrugAspirin
Xuanwu Hospital, Beijing
Phase 3
300
Beijing
2026-06
Not yet open
Peking University
Not applicable
1,200
Beijing, Weifang
2026-06
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
144
Beijing, Changchun, Changsha, Hangzhou, Kunming, Nanjing, Nanning, Qingdao
2026-05-31
Not yet open
Beijing Hospital of Traditional Chinese Medicine
Phase 3
636
Beijing, Chengdu, Chongqing, Guangzhou, Guizhou, Haozhou, Hebei, Heilongjiang
2026-05-31
Not yet open
Keymed Biosciences Co.Ltd
Phase 2
120
Beijing
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Beijing, Changchun, Chaoyang District, Chengdu, Guangzhou, Hangzhou, Nanchang, Nanjing
2026-05-31
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1
7
Beijing
2026-05-31
Recruiting
Peking University Cancer Hospital & Institute
Not applicable
20
Beijing
2026-05-31
Not yet open
Peking Union Medical College Hospital
Observational
2,000
Hefei, Beijing, Linxia, Qinzhou, Guiyang, Zunyi, Tangshan, Mudanjiang
2026-05-30
Recruiting
Pre-incisional Infiltration With Ropivacaine Plus Diprospan for Relieving Postoperative Pain After Laparoscopic Surgery
NCT07626463Laparoscopic Surgery, Laparoscopic Appendectomy, Laparoscopic Cholecystectomy, Laparoscopic Hernia Repair Surgery
DrugPre-incisional infiltration with ropivacaine alone
Beijing Tiantan Hospital
Not applicable
150
Beijing
2026-05-30
Not yet open
Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI
NCT07551414NSCLC (Non-small Cell Lung Carcinoma), Leptomeningeal Metastasis, EGFR-TKI Sensitizing Mutation, Zorifertinib
DrugZorifertinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
38
Beijing
2026-05-30
Recruiting
The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
NCT07457125Mild to Moderate Alzheimer's Disease
Xuanwu Hospital, Beijing
Phase 1/2
33
Beijing
2026-05-30
Recruiting
Beijing Tiantan Hospital
Not applicable
100
Beijing
2026-05-30
Not yet open
Real-World Data Linkage Research Platform
NCT07635355Chronic Diseases, Sub-optimal Health
Beijing Friendship Hospital
Observational
300,000
Beijing
2026-05-30
Not yet open
Peking University People's Hospital
Phase 3
192
Beijing
2026-05-30
Active, closed
Peking University
Observational
150
Beijing
2026-05-29
Not yet open
Linno Pharmaceuticals, Inc.
Phase 2
48
Beijing
2026-05-29
Recruiting
Beijing Artemis Medical Beauty Clinic
Not applicable
50
Beijing
2026-05-29
Recruiting
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
NCT07528027Hypertension With Overweight or Obesity
DrugHRS-7535
Shandong Suncadia Medicine Co., Ltd.
Phase 3
648
Beijing, Harbin
2026-05-29
Recruiting
Peking University People's Hospital
Early Phase 1
18
Beijing
2026-05-29
Active, closed
Chengdu Kangnuoxing Biopharma,Inc.
Observational
600
Beijing
2026-05-29
Recruiting
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
9,262
Beijing
2026-05-29
Not yet open
A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
NCT07583316Lung Cancer (Locally Advanced or Metastatic), Esophagus Cancer, Head and Neck Cancer, Hepatocellular Carcinoma (HCC)
Corregene Biotechnology Co., Ltd
Phase 1
192
Beijing
2026-05-29
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Hefei, Beijing, Fuzhou, Xiamen, Shijiazhuang, Zhengzhou, Shiyan, Wuhan
2026-05-28
Recruiting
UCB Biopharma SRL
Phase 3
120
Beijing, Chengdu, Chongqing, Nanchang, Suzhou
2026-05-27
By invitation
Beijing Friendship Hospital
Not applicable
140
Beijing
2026-05-27
Recruiting
Shanghai Henlius Biotech
Phase 2/3
706
Beijing
2026-05-27
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
178
Beijing, Harbin, Tianjin
2026-05-27
Not yet open
Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)
NCT07616414Non-valvular Atrial Fibrillation (NVAF), Thromboembolism, Cardiac Implantable Electronic Device, Perioperative Bleeding
Fu Wai Hospital, Beijing, China
Not applicable
424
Beijing
2026-05-26
Recruiting
AstraZeneca
Phase 4
100
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2026-05-26
Recruiting
Jecho Biopharmaceuticals Co., Ltd.
Phase 1/2
30
Beijing
2026-05-26
Recruiting
H. Lundbeck A/S
Phase 1
10
Beijing, Shanghai Shi, Chengdu
2026-05-26
Not yet open
Chinese PLA General Hospital
Observational
3,000
Beijing
2026-05-25
Not yet open
AI-GF-GNW on Prolonged Grief Reactions
NCT07589088Artificial Intelligence (AI), Prolonged Grief Symptoms, Depression - Major Depressive Disorder, Anxiety
Peking University
Not applicable
126
Beijing
2026-05-25
Recruiting
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
NCT07617740REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
DrugIASO207
Peking University People's Hospital
Early Phase 1
18
Beijing
2026-05-25
Active, closed
Shanghai Lanyi Therapeutics Co., Ltd.
Phase 1
12
Beijing
2026-05-25
Recruiting
Shanghai Henlius Biotech
Phase 1
258
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou
2026-05-25
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
376
Beijing
2026-05-24
Not yet open
Beijing Anzhen Hospital
Observational
600
Beijing
2026-05-24
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Beijing, Changzhou, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou
2026-05-23
Recruiting
Yanbing Yu
Not applicable
142
Beijing, Nanning, Shijiazhuang, Nanjing, Nantong, Nanchang, Shanghai, Tianjin
2026-05-23
Recruiting
AbbVie
Phase 3
990
Beijing, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan, Wuxi, Changchun
2026-05-22
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Beijing, Changsha, Changzhou, Chengdu, Chongqing, Foshan, Guangzhou, Hangzhou
2026-05-22
Recruiting
BeOne Medicines
Phase 3
1,056
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shantou, Nanning
2026-05-22
Recruiting
Chinese Adults With Kidney Disease
NCT07522099Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G), IC-MPGN
DrugTelitacicept
ADARx Pharmaceuticals, Inc.
Phase 2
30
Shenzhen, Guiyang, Zhengzhou, Baotou, Wuxi, Yantai, Beijing, Shandong
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Nanjing, Shanghai, Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou
2026-05-21
Recruiting
Gang Hou
Not applicable
110
Beijing
2026-05-20
Recruiting
Biotech Pharmaceutical Co., Ltd.
Phase 1/2
228
Beijing
2026-05-20
Active, closed
Telerehabilitation for Patellofemoral Pain
NCT07557784Patellofemoral Pain, PFP
Beijing Sport University
Not applicable
106
Beijing
2026-05-20
Recruiting
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
74
Beijing
2026-05-20
Recruiting
Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
NCT07614477Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd.
Phase 2
45
Beijing, Tianjin
2026-05-20
Active, closed
Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer
NCT07745322Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms
Peking University Cancer Hospital & Institute
Observational
270
Beijing
2026-05-20
Recruiting
Huahui Health
Phase 1/2
30
Bengbu, Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou
2026-05-19
Not yet open
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
NCT07586865Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall, Acute Myocardial Infarction With ST Elevation, Acute Myocardial Infarction of Left Ventricle
Beijing Northland Biotech. Co., Ltd.
Phase 2
189
Beijing
2026-05-18
Recruiting
Xuanwu Hospital, Beijing
Observational
10,050
Beijing
2026-05-18
Recruiting
China-Japan Friendship Hospital
Not applicable
80
Beijing
2026-05-18
Recruiting
Beijing Hospital
Not applicable
100
Beijing
2026-05-17
Recruiting
Takeda
Phase 2
222
Beijing, Nanyang, Xuzhou, Jinan, Liaocheng, Linyi, Datong, Linfen
2026-05-17
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Active, closed
Gait Retraining for Runners With Patellofemoral Pain
NCT07557797Patellofemoral Pain, PFP
Beijing Sport University
Not applicable
44
Beijing
2026-05-15
Recruiting
Biokin (Shanghai) Biopharmaceutical Co., Ltd.
Phase 3
438
Beijing
2026-05-15
Not yet open
China National Center for Cardiovascular Diseases
Phase 4
104
Beijing
2026-05-15
Not yet open
Beijing Tongren Hospital
Phase 2
34
Beijing
2026-05-15
Recruiting
Hoffmann-La Roche
Phase 3
138
Beijing
2026-05-15
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Recruiting
AbbVie
Phase 1/2
210
Beijing, Guangzhou
2026-05-15
Not yet open
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
30
Beijing
2026-05-15
Not yet open
The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.
NCT07592754Neuromyelitis Optica Spectrum Disease (NMOSD)
DrugKsvcbd
Chinese PLA General Hospital
Early Phase 1
18
Beijing
2026-05-15
Not yet open
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Not applicable
66
Beijing
2026-05-15
Not yet open
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
NCT07486648Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell), Advanced Non-small-cell Lung Cancer
DrugsCapivasertib·Osimertinib
Shanxi Province Cancer Hospital
Phase 1/2
53
Beijing, Taiyuan
2026-05-15
Recruiting
Hongying Jiang, MD
Not applicable
120
Beijing
2026-05-15
Recruiting
Ipsen
Phase 3
350
Beijing, Guangzhou, Zhengzhou, Nanchang, Changchun, Jinan, Shanghai, Tianjin
2026-05-14
Recruiting
Levetiracetam for Seizure Prevention After Brain Tumor Surgery
NCT07239115Postoperative Seizures After Brain Tumor Surgery
DrugLevetiracetam
Beijing Tiantan Hospital
Phase 3
558
Beijing
2026-05-14
Active, closed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
45
Beijing
2026-05-14
Not yet open
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
NCT07630363Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With Immunotherapy
DrugsAxitinib·Atorvastatin·Toripalimab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
40
Beijing
2026-05-14
Recruiting
Xuanwu Hospital, Beijing
Phase 4
868
Beijing, Shandong
2026-05-14
Recruiting
RemeGen Co., Ltd.
Phase 2/3
80
Beijing, Chongqing, Fuzhou, Meizhou, Nanjing, Shijiazhuang, Zhengzhou, Wuhan
2026-05-12
Recruiting
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
NCT07444372Obstructive Sleep Apnea, Sleep Disorder (Disorder), Atrial Fibrillation (AF), Sleep Disordered Breathing (SDB)
Beijing Anzhen Hospital
Not applicable
658
Beijing, Fuzhou, Zhangzhou, Nanning, Langfang, Shijiazhuang, Xingtai, Harbin
2026-05-12
Recruiting
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Shijiazhuang
2026-05-11
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Beijing, Lanzhou, Foshan, Guangzhou, Harbin, Changsha, Baotou, Nanjing
2026-05-11
Not yet open
Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures
NCT07575256PCL - Posterior Cruciate Ligament Deficiency, Posterior Cruciate Ligament Tear, PCL - Posterior Cruciate Ligament Rupture
Beijing Tsinghua Chang Gung Hospital
Not applicable
22
Beijing
2026-05-10
Not yet open
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
NCT07605624Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation, Tricuspid Regurgitation
Beijing Anzhen Hospital
Observational
5,500
Beijing
2026-05-10
Recruiting
Liping Dou
Early Phase 1
18
Beijing
2026-05-09
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Beijing
2026-05-08
Recruiting
A Clinical Study of Cizutamig in Thyroid Eye Disease
NCT07597200Thyroid Eye Disease, TED
Candid Therapeutics
Phase 1
38
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Changsha, Wuhan, Nanchang
2026-05-08
Recruiting
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-05-08
Recruiting
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3
874
Beijing
2026-05-07
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285AML, Refractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1
27
Beijing
2026-05-07
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
Beijing, Xiamen, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang, Jinan
2026-05-06
Not yet open
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
NCT07593365Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain Alleviation
Peking University People's Hospital
Not applicable
216
Beijing
2026-05-06
Recruiting
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
NCT07316270AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous
Beijing Anzhen Hospital
Not applicable
646
Hefei, Beijing, Xiamen, Harbin, Changchun, Xi'an
2026-05-06
Not yet open
Xuanwu Hospital, Beijing
Not applicable
60
Beijing
2026-05-06
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Beijing, Guangzhou, Meizhou, Nanning, Hong Kong, Wuhan, Nanjing, Nanchang
2026-05-06
Recruiting
Novo Nordisk A/S
Phase 3
300
Beijing, Guangzhou, Shenzhen, Luoyang, Nanjing, Tianjin
2026-05-05
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 3
912
Beijing
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Beijing, Nanjing, Suzhou, Zhenjiang, Huzhou
2026-05-05
Recruiting
Gan Lijun
Not applicable
2,170
Beijing, Haikou, Harbin, Nanchang, Heze, Jinan, Jining, Liaocheng
2026-05-04
Recruiting
AstraZeneca
Phase 3
670
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanjing
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Beijing, Fuzhou, Guangzhou, Zhengzhou, Shanghai
2026-05-03
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
300
Beijing
2026-05-02
Not yet open
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
NCT07617675AKI - Acute Kidney Injury, Cardiac Surgical Procedures, Cardiopulmonary Bypass
China National Center for Cardiovascular Diseases
Phase 4
694
Beijing
2026-05-01
Not yet open
Beijing Obstetrics and Gynecology Hospital
Not applicable
200
Beijing
2026-05-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
204
Beijing
2026-05-01
Recruiting
China-Japan Friendship Hospital
Not applicable
200
Beijing
2026-05-01
By invitation
Chinese PLA General Hospital
Early Phase 1
60
Beijing
2026-05-01
Not yet open
Beijing Tiantan Hospital
Not applicable
40
Beijing
2026-05-01
By invitation
Acute Kidney Injury in Critically Ill Patients
NCT07653321Acute Kidney Injury
Beijing Chao Yang Hospital
Observational
23,600
Beijing
2026-05-01
Not yet open
Longbio Pharma (Suzhou) Co., Ltd.
Phase 2
100
Beijing
2026-05-01
Not yet open
Capital University of Physical Education and Sports, China
Not applicable
60
Beijing
2026-05-01
Recruiting
Beijing Tongren Hospital
Phase 2
40
Beijing
2026-05-01
Not yet open
Chinese PLA General Hospital
Phase 2
60
Beijing
2026-05-01
Not yet open
Ming Yang
Phase 1
24
Beijing
2026-05-01
Not yet open
Peking Union Medical College Hospital
Phase 1
18
Beijing
2026-05-01
Recruiting
Peking University First Hospital
Phase 3
192
Beijing
2026-05-01
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
651
Beijing
2026-05-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
50
Beijing
2026-05-01
Recruiting
Peking University People's Hospital
Observational
60
Beijing
2026-05-01
Not yet open
Huan Ye
Phase 1
9
Beijing
2026-05-01
Not yet open
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment
NCT07514988Acute Coronary Syndromes (ACS)
China National Center for Cardiovascular Diseases
Not applicable
60
Beijing
2026-05-01
Not yet open
Beijing Tongren Hospital
Not applicable
120
Beijing
2026-05-01
Not yet open
LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients
NCT07521488Coronary Artery Bypass Grafting, Heart Valve Disease, Aortic Aneurysm, Aortic Dissection
Beijing Anzhen Hospital
Not applicable
500
Beijing
2026-05-01
Recruiting
Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy
NCT07668037Non-Small Cell Carcinoma of Lung, Immunotherapy, Advanced Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
600
Beijing
2026-05-01
Recruiting
Safety and Efficacy of a Novel Composite-Tip Guiding Catheter in Transcarotid Artery Stenting Via Transradial Access
NCT07377422Transradial Carotid Artery Stenting, Novel Composite-tip Guiding Catheter
Beijing Anzhen Hospital
Not applicable
204
Beijing
2026-05-01
Not yet open
Beijing Chao Yang Hospital
Phase 4
210
Beijing
2026-05-01
Not yet open
Capital Medical University
Not applicable
200
Beijing
2026-05
Not yet open
Maternal-Fetal Heart Sound/Electrocardiogram Monitoring and Cardiac Risk Early Warning
NCT07526662Pregnancy-Associated Heart Disease, Fetal Congenital Heart Disease, Autoimmune-Related Fetal Heart Block, Perinatal Adverse Events
Yihua He,MD
Observational
1,000
Beijing
2026-05
Not yet open
China-Japan Friendship Hospital
Not applicable
108
Beijing
2026-05
Not yet open
Yunnan Baiyao Group Co., Ltd.
Phase 1/2
146
Beijing
2026-05
Not yet open
Kunming Pharmaceuticals, Inc.
Phase 2
100
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shenyang, Kunming, Hangzhou
2026-04-30
Recruiting
Eli Lilly and Company
Phase 3
140
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei
2026-04-30
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beijing, Shanghai
2026-04-30
Recruiting
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
Phase 1/2
120
Beijing, Jilin City, Fuzhou, Xiamen, Lanzhou, Guangzhou, Guiyang, Zhengzhou
2026-04-30
Recruiting
LaNova Medicines Limited
Phase 3
400
Beijing
2026-04-30
Recruiting
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
200
Beijing
2026-04-30
Not yet open
Beijing GoBroad Hospital
Phase 2
23
Beijing
2026-04-30
Recruiting
Exosome Therapy for Male Androgenetic Alopecia
NCT07693244Androgenetic Alopecia (AGA)
Zhang Han
Phase 2
120
Beijing
2026-04-30
Recruiting
The Effect of Sequential Therapy on Alzheimer's Disease
NCT07768579Mild Cognitive Impairment Due to Alzheimer Disease, Alzheimer Disease
Dongzhimen Hospital, Beijing
Observational
600
Beijing
2026-04-30
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
450
Beijing
2026-04-30
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
10
Beijing
2026-04-30
Not yet open
Tasly Pharmaceutical Group Co., Ltd
Phase 3
450
Beijing
2026-04-30
Not yet open
Gan & Lee Pharmaceuticals.
Phase 1
65
Beijing
2026-04-30
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Observational
200
Beijing
2026-04-30
Not yet open
Tasly Pharmaceutical Group Co., Ltd
Phase 2/3
180
Beijing
2026-04-30
Recruiting
AstraZeneca
Observational
3,000
Beijing
2026-04-29
Recruiting
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-29
Recruiting
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer
NCT07497386Unresectable Locally Recurrent Breast Cancer, Unresectable Locally Metastatic Breast Cancer
DrugsTrastuzumab Rezetecan·Trastuzumab deruxtecan
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
150
Beijing
2026-04-28
Active, closed
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
Bayer
Phase 2
250
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Shijiazhuang, Harbin, Zhengzhou
2026-04-27
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NCT07557225Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer
Peking University First Hospital
Not applicable
200
Beijing
2026-04-27
Recruiting
Hoffmann-La Roche
Phase 3
360
Beijing, Fuzhou, Guangzhou, Chengdu, Tianjin
2026-04-27
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
105
Hefei, Beijing, Chongqing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Zhengzhou
2026-04-27
Not yet open
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-04-27
Not yet open
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）
NCT07317804Aortic Stenosis, TAVI, TAVI(Transcatheter Aortic Valve Implantation)
China National Center for Cardiovascular Diseases
Phase 4
212
Beijing
2026-04-26
Recruiting
Peking University First Hospital
Not applicable
70
Beijing
2026-04-25
Recruiting
A Study in Adults With Desmoid Tumors
NCT07541430Desmoid Tumor
DrugES014
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 2
50
Beijing
2026-04-24
Recruiting
A Novel Two-Tooth Clip for ESD and EFTR of GIST
NCT07581977GIST - Gastrointestinal Stromal Tumor
Affiliated Hospital to Academy of Military Medical Sciences
Not applicable
60
Beijing
2026-04-24
Recruiting
AstraZeneca
Phase 3
230
Beijing, Bengbu, Cangzhou, Changsha, Chengdu, Chongqing, Foshan, Fuzhou
2026-04-24
Recruiting
Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
NCT07670286Pancreatic Cancer, Cachexia; Cancer; Sarcopenia
Peking Union Medical College Hospital
Observational
500
Beijing
2026-04-24
Recruiting
Gang Hou
Phase 1/2
105
Beijing
2026-04-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Beijing, Chongqing, Guangzhou, Zhuhai, Wuhan, Changsha, Nanjing, Nanchang
2026-04-23
Recruiting
Eli Radiopharma
Phase 1
18
Beijing
2026-04-23
Recruiting
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 1
56
Beijing
2026-04-23
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
410
Beijing
2026-04-23
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Recruiting
Daoyin Technique for Improving Exercise Endurance in IPF
NCT07019714Idiopathic Pulmonary Fibrosis
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Not applicable
236
Beijing, Zhengzhou, Shenyang
2026-04-22
Recruiting
BioNTech SE
Phase 3
736
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Hefei, Nanchang
2026-04-22
Not yet open
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599Ischemic Cerebral Infarction
Beijing Tiantan Hospital
Phase 3
4,810
Fuyang, Wuhu, Beijing, Chongqing, Ningde, Dingxi, Jiuquan, Lanzhou
2026-04-22
Active, closed
AstraZeneca
Not applicable
4,000
Beijing, Changlexi, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangdong Province
2026-04-21
Recruiting
Joint Biosciences Ltd.
Phase 1
18
Beijing
2026-04-21
Not yet open
Beijing Chao Yang Hospital
Not applicable
70
Beijing
2026-04-20
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
466
Beijing
2026-04-20
Active, closed
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 1
40
Beijing
2026-04-20
Not yet open
RemeGen Co., Ltd.
Phase 3
260
Beijing
2026-04-20
Not yet open
Beijing Tiantan Hospital
Observational
120
Beijing
2026-04-20
Not yet open
Chinese PLA General Hospital
Observational
180
Beijing
2026-04-20
Recruiting
Beijing Shijitan Hospital, Capital Medical University
Observational
129
Beijing, Harbin, Dalian, Weifang
2026-04-20
Recruiting
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
NCT07366112Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
Peking University People's Hospital
Phase 2
158
Beijing
2026-04-20
Not yet open
Peking Union Medical College Hospital
Early Phase 1
408
Beijing
2026-04-20
Recruiting
Boehringer Ingelheim
Phase 2
405
Beijing, Changchun, Changsha, Guangzhou, Linfen, Nanjing, Ningbo, Shanghai
2026-04-20
Recruiting
Beijing Friendship Hospital
Observational
5,000
Beijing
2026-04-17
Recruiting
Shanghai Henlius Biotech
Phase 1
138
Beijing, Shanghai
2026-04-17
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
90
Beijing
2026-04-17
Not yet open
Peking University Third Hospital
Not applicable
400
Beijing
2026-04-17
Recruiting
Ipsen
Observational
20
Beijing, Chongqing, Hunan, Nanjing, Shanghai, Xiamen
2026-04-16
Recruiting
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-15
Recruiting
Beijing 302 Hospital
Phase 2
48
Beijing
2026-04-15
Recruiting
Corticosteroids in Hyperinflammatory Phenotype of Critical Illness
NCT07511582Sepsis, Acute Respiratory Distress Syndrome
DrugMethylprednisolone
Bin Du
Phase 2
150
Beijing
2026-04-15
Recruiting
Xuanwu Hospital, Beijing
Not applicable
264
Beijing, Fuzhou, Shijiazhuang, Harbin, Nanyang, Zhengzhou, Baotou, Xi'an
2026-04-15
Not yet open
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
170
Beijing
2026-04-15
Recruiting
Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II
NCT07396077Spine Degeneration, Lumbar Degenerative Disease, Frail Elderly, Enhanced Recovery After Surgery (ERAS) Protocol
Xuanwu Hospital, Beijing
Not applicable
248
Beijing
2026-04-15
Not yet open
yilong Wang
Not applicable
6
Beijing
2026-04-15
Active, closed
AI-Assisted Mindfulness Intervention in Emotional Distress
NCT07542561Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress
Xinghua Liu
Not applicable
550
Beijing
2026-04-15
Recruiting
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 3
752
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-04-15
Recruiting
A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07493135Relapsed/Refractory Multiple Myeloma
Suzhou Immunofoco Biotechnology Co., Ltd
Early Phase 1
30
Beijing, Chongqing, Shanghai, Zhengzhou
2026-04-14
Recruiting
Eli Lilly and Company
Phase 2
65
Beijing, Shanghai, Tianjin
2026-04-14
Recruiting
Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
NCT07525986Laparoscopic Surgery, Visceral Pain, Postoperative, Anrikefon, Patient-controlled Intravenous Analgesia
DrugsAnrikefon·Morphine
Peking University First Hospital
Phase 4
140
Beijing, Shenzhen, Changsha
2026-04-14
Recruiting
Affiliated Hospital to Academy of Military Medical Sciences
Early Phase 1
20
Beijing
2026-04-14
Recruiting
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
DrugLY4005130
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Recruiting
Xuanwu Hospital, Beijing
Phase 3
246
Beijing
2026-04-14
Recruiting
Beijing Tsinghua Chang Gung Hospital
Observational
40
Beijing
2026-04-13
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
280
Beijing
2026-04-13
Recruiting
Beijing Tsinghua Chang Gung Hospital
Observational
108
Beijing
2026-04-13
Recruiting
Boehringer Ingelheim
Phase 3
670
Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-04-13
Recruiting
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Shijiazhuang, Jinan, Qingdao, Taiyuan, Tianjin
2026-04-13
Recruiting
BeOne Medicines
Phase 1
84
Beijing, Chongqing, Fuzhou, Guangzhou, Yichang, Shanghai
2026-04-13
Recruiting
Beijing Chao Yang Hospital
Observational
122
Beijing
2026-04-10
Recruiting
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
NCT07724847Axial Spondyloarthritis (AxSpA), Spondyloarthritis (SpA), Chronic Back Pain
Chinese PLA General Hospital
Observational
247
Beijing
2026-04-10
Recruiting
Peking University Sixth Hospital
Not applicable
120
Beijing, Yanan
2026-04-10
Rows per page Showing 501–1000 of 5576
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,576 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,389 of the 5,576 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 990 have not yet opened recruitment, 1,019 are active but closed to new participants, and 178 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.